Skip to main navigation Skip to search Skip to main content

Macrophage-targeted single-atom catalytic therapeutics recover SHPK-mediated metabolic homeostasis

  • Shan He
  • , Mengzhen Zhang
  • , Zejin Zhang
  • , Wenhui Wei
  • , Yingqian Zhou
  • , Nan Ren
  • , Jingru Wang
  • , Jiatao Zhang*
  • , Chuanan Shen
  • *Corresponding author for this work
  • Chinese PLA Hospital
  • Nanfang Hospital
  • Beijing Institute of Technology

Research output: Contribution to journal › Article › peer-review

Abstract

Persistent inflammation-driven oxidative stress impairs tissue remodeling in chronic wounds, a process closely linked to macrophage dysfunction. Here, we report a novel single-atom ruthenium nanozyme (RuSAC@PS) with Ru–N4 coordination and phosphatidylserine targeting for macrophage delivery. This nanozyme achieves dual exogenous and endogenous ROS scavenging. It eliminates exogenous ROS through intrinsic SOD/CAT-like activities, with ultralow metal loading (~0.3 wt%) ensuring high catalytic efficiency and biocompatibility. Crucially, we first demonstrate that this artificial catalyst restores SHPK-mediated metabolic homeostasis to suppress endogenous ROS overproduction intracellularly. This dual action breaks the ROS–NF-κB feedback loop, reprograms macrophage metabolism from glycolysis to oxidative phosphorylation, and promotes M2-type polarization. In diabetic wound models, RuSAC@PS accelerates healing, enhances neovascularization, and improves collagen remodeling to reduce scarring. This work establishes a new paradigm for targeted single-atom nanozymes that actively modulate macrophage metabolism and polarization, offering a highly translatable catalytic strategy for chronic inflammatory disorders.

Original languageEnglish
Article number183575
JournalChemical Engineering Journal
Volume549
DOIs
Publication statusPublished - 1 Dec 2026
Externally publishedYes

Keywords

  • Diabetic wound healing
  • M2 polarization
  • Macrophage targeting
  • Metabolic reprogramming
  • ROS scavenging
  • Single-atom nanozymes

Fingerprint

Dive into the research topics of 'Macrophage-targeted single-atom catalytic therapeutics recover SHPK-mediated metabolic homeostasis'. Together they form a unique fingerprint.

Cite this